Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $42,843 | 26 | 80.3% |
| Food and Beverage | $8,940 | 430 | 16.8% |
| Travel and Lodging | $1,047 | 10 | 2.0% |
| Education | $493.65 | 5 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $18,544 | 102 | $0 (2024) |
| ABBVIE INC. | $12,903 | 61 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $8,265 | 19 | $0 (2021) |
| Biohaven Pharmaceutical Holding Company Ltd. | $8,040 | 23 | $0 (2022) |
| PFIZER INC. | $595.89 | 34 | $0 (2024) |
| Lilly USA, LLC | $507.54 | 32 | $0 (2024) |
| UCB, Inc. | $417.43 | 15 | $0 (2024) |
| Allergan, Inc. | $367.50 | 18 | $0 (2021) |
| US WorldMeds, LLC | $351.88 | 7 | $0 (2020) |
| GENZYME CORPORATION | $315.26 | 9 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $24,074 | 128 | ABBVIE INC. ($12,106) |
| 2023 | $8,480 | 107 | Teva Pharmaceuticals USA, Inc. ($7,065) |
| 2022 | $9,916 | 110 | Biohaven Pharmaceutical Holding Company Ltd. ($8,040) |
| 2021 | $9,254 | 72 | Biohaven Pharmaceuticals, Inc. ($8,251) |
| 2020 | $962.70 | 46 | Allergan, Inc. ($355.97) |
| 2019 | $89.31 | 1 | US WorldMeds, LLC ($89.31) |
| 2018 | $352.58 | 5 | Teva Pharmaceuticals USA, Inc. ($225.86) |
| 2017 | $193.82 | 2 | Teva Pharmaceuticals USA, Inc. ($110.25) |
All Payment Transactions
471 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $7.56 | General |
| Category: Central Nervous System | ||||||
| 11/26/2024 | ABBVIE INC. | QULIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,625.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $27.15 | General |
| Category: Neurology | ||||||
| 11/21/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $10.38 | General |
| Category: Central Nervous System | ||||||
| 11/19/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: PAIN | ||||||
| 11/13/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $14.04 | General |
| 11/12/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.80 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $28.95 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $9.75 | General |
| Category: Central Nervous System | ||||||
| 11/07/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: Rare Disease | ||||||
| 11/04/2024 | MDD US Operations, LLC | Apokyn (Drug) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: APOMORPHINE HYDROCHLORIDE | ||||||
| 10/29/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 10/28/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $840.00 | General |
| Category: Central Nervous System | ||||||
| 10/25/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Neuroscience | ||||||
| 10/24/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: Neuroscience | ||||||
| 10/22/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: PAIN | ||||||
| 10/16/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: Central Nervous System | ||||||
| 10/15/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: Neurology | ||||||
| 10/11/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Central Nervous System | ||||||
| 10/10/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: Neurology | ||||||
| 10/08/2024 | ABBVIE INC. | UBRELVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,312.50 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2024 | MDD US Operations, LLC | Apokyn (Drug) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: APOMORPHINE HYDROCHLORIDE | ||||||
| 10/04/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: Neuroscience | ||||||
| 10/03/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 624 | 839 | $163,260 | $75,875 |
| 2022 | 10 | 657 | 898 | $189,789 | $89,493 |
| 2021 | 9 | 549 | 730 | $164,103 | $85,413 |
| 2020 | 8 | 414 | 522 | $123,071 | $61,690 |
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 249 | 381 | $66,062 | $29,995 | 45.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 90 | 90 | $29,883 | $12,976 | 43.4% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 76 | 132 | $20,397 | $9,654 | 47.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 52 | 59 | $10,647 | $7,116 | 66.8% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 28 | 28 | $8,550 | $3,534 | 41.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 26 | 26 | $6,824 | $3,057 | 44.8% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 17 | 17 | $6,227 | $2,618 | 42.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 40 | 46 | $5,486 | $2,548 | 46.4% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 18 | 18 | $4,178 | $1,815 | 43.4% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 14 | 14 | $2,549 | $1,319 | 51.8% |
| 11105 | Punch biopsy, each additional skin growth | Office | 2023 | 14 | 28 | $2,459 | $1,244 | 50.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 251 | 401 | $69,529 | $33,251 | 47.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 142 | 142 | $47,148 | $20,772 | 44.1% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 79 | 149 | $23,023 | $11,195 | 48.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 60 | 75 | $13,534 | $8,713 | 64.4% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 40 | 40 | $12,215 | $4,486 | 36.7% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2022 | 11 | 12 | $6,842 | $3,187 | 46.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 22 | 22 | $5,774 | $2,512 | 43.5% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 14 | 14 | $5,128 | $2,113 | 41.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 26 | 30 | $3,578 | $1,993 | 55.7% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2022 | 12 | 13 | $3,017 | $1,269 | 42.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 193 | 292 | $50,630 | $26,792 | 52.9% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 143 | 143 | $47,480 | $22,226 | 46.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 81 | 109 | $19,669 | $13,904 | 70.7% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 54 | 108 | $16,688 | $8,664 | 51.9% |
About Dr. Gary Dubisky, DO
Dr. Gary Dubisky, DO is a Neurology healthcare provider based in Gastonia, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/01/2005. The National Provider Identifier (NPI) number assigned to this provider is 1144220161.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Dubisky, DO has received a total of $53,322 in payments from pharmaceutical and medical device companies, with $24,074 received in 2024. These payments were reported across 471 transactions from 44 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($42,843).
As a Medicare-enrolled provider, Dubisky has provided services to 2,244 Medicare beneficiaries, totaling 2,989 services with total Medicare billing of $312,471. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Gastonia, NC
- Active Since 08/01/2005
- Last Updated 01/17/2020
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1144220161
Products in Payments
- NURTEC ODT (Drug) $16,642
- Austedo XR (Drug) $13,825
- UBRELVY (Drug) $10,031
- AUSTEDO (Drug) $3,954
- QULIPTA (Drug) $2,965
- EMGALITY (Drug) $359.47
- AUBAGIO (Drug) $315.26
- MYOBLOC (Biological) $234.93
- AJOVY (Drug) $216.44
- KESIMPTA (Drug) $211.38
- Briviact (Drug) $188.45
- VYVGART HYTRULO (Drug) $177.30
- GOCOVRI (Drug) $172.48
- Rystiggo (Drug) $169.88
- BOTOX (Biological) $164.36
- Trudhesa (Drug) $159.53
- Aimovig (Biological) $156.56
- APOKYN (Drug) $149.13
- AJOVY (Biological) $145.41
- VUMERITY (Drug) $122.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Gastonia
Dr. Ashok Pillai, M.d, M.D
Neurology — Payments: $6,750
Dr. Catherine Fletchall Belle, D.o, D.O
Neurology — Payments: $1,738
Dr. Andrew Becker, Md, MD
Neurology — Payments: $1,354
Mr. Sunil Mehta, M.d, M.D
Neurology — Payments: $728.19
Dr. Steven Dibert, Md, MD
Neurology — Payments: $434.10
Suzanne Nutt, M.d, M.D
Neurology